Zhu, M., Bassam Sonbol, M., Halfdanarson, T., Hobday, T., Ahn, D., Ma, W. W., & Bekaii‐Saab, T. (2020). Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors. Oncologist.

Zhu, Mojun, Mohamad Bassam Sonbol, Thorvardur Halfdanarson, Timothy Hobday, Daniel Ahn, Wen Wee Ma, i Tanios Bekaii‐Saab. "Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors." Oncologist 2020.

Zhu, Mojun, et al. "Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors." Oncologist 2020.